Previous Close | 75.87 |
1-Year Change | 40.53% |
6-Months Change | 32.87% |
3-Months Change | 19.93% |
Moving Avg (50d) | 68.99 |
Moving Avg (200d) | 61.771 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 17.0B |
Beta (3-Years) | 0.51 |
Revenue Growth (ttm) | 8.35% |
Net Profit Margin (ttm) | 11.78% |
Return On Assets (ttm) | 6.65% |
EPS (ttm) | 1.88 |
PE Ratio (ttm) | 40.36 |
Dividend Yield | % |
Asset Description: | Incyte Corporation |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-11-12 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
74.705 | 76.902 | 78.367 | 80.564 | 84.226 | 87.888 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.